The global Plant Sources Anti Cancer Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

Market: The market for plant sources anti-cancer agents is driven by the growing interest in natural and plant-based treatments for cancer. These compounds are being studied for their potential therapeutic effects and are expected to gain significance in cancer research and treatments.

This report aims to provide a comprehensive presentation of the global market for Plant Sources Anti Cancer Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plant Sources Anti Cancer Agents.

Report Scope

The Plant Sources Anti Cancer Agents market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plant Sources Anti Cancer Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Plant Sources Anti Cancer Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Plant Sources Anti Cancer Agents Market Report

Report Metric	Details
Report Name	Plant Sources Anti Cancer Agents Market
Segment by Type	Paclitaxel Vinorelbine Irinotecan Hydroxycamptothecin Docetaxel Other
Segment by Application	Ovarian Cancer Cervical Cancer Breast Cancer Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, Hainan Yew Pharm, Jiangsu Yew Biotechnology, West-Ward Pharmaceuticals, Pfizer, Actiza Pharmaceutical, Getwell, Taj Pharma, Cipla, Salius
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Plant Sources Anti Cancer Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Plant Sources Anti Cancer Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Plant Sources Anti Cancer Agents Market report?

Ans: The main players in the Plant Sources Anti Cancer Agents Market are Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, Hainan Yew Pharm, Jiangsu Yew Biotechnology, West-Ward Pharmaceuticals, Pfizer, Actiza Pharmaceutical, Getwell, Taj Pharma, Cipla, Salius

What are the Application segmentation covered in the Plant Sources Anti Cancer Agents Market report?

Ans: The Applications covered in the Plant Sources Anti Cancer Agents Market report are Ovarian Cancer, Cervical Cancer, Breast Cancer, Other

What are the Type segmentation covered in the Plant Sources Anti Cancer Agents Market report?

Ans: The Types covered in the Plant Sources Anti Cancer Agents Market report are Paclitaxel, Vinorelbine, Irinotecan, Hydroxycamptothecin, Docetaxel, Other

1 Plant Sources Anti Cancer Agents Market Overview

1.1 Product Overview and Scope of Plant Sources Anti Cancer Agents

1.2 Plant Sources Anti Cancer Agents Segment by Type

1.2.1 Global Plant Sources Anti Cancer Agents Market Value Comparison by Type (2024-2030)

1.2.2 Paclitaxel

1.2.3 Vinorelbine

1.2.4 Irinotecan

1.2.5 Hydroxycamptothecin

1.2.6 Docetaxel

1.2.7 Other

1.3 Plant Sources Anti Cancer Agents Segment by Application

1.3.1 Global Plant Sources Anti Cancer Agents Market Value by Application: (2024-2030)

1.3.2 Ovarian Cancer

1.3.3 Cervical Cancer

1.3.4 Breast Cancer

1.3.5 Other

1.4 Global Plant Sources Anti Cancer Agents Market Size Estimates and Forecasts

1.4.1 Global Plant Sources Anti Cancer Agents Revenue 2019-2030

1.4.2 Global Plant Sources Anti Cancer Agents Sales 2019-2030

1.4.3 Global Plant Sources Anti Cancer Agents Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Plant Sources Anti Cancer Agents Market Competition by Manufacturers

2.1 Global Plant Sources Anti Cancer Agents Sales Market Share by Manufacturers (2019-2024)

2.2 Global Plant Sources Anti Cancer Agents Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Plant Sources Anti Cancer Agents Average Price by Manufacturers (2019-2024)

2.4 Global Plant Sources Anti Cancer Agents Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Plant Sources Anti Cancer Agents, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Plant Sources Anti Cancer Agents, Product Type & Application

2.7 Plant Sources Anti Cancer Agents Market Competitive Situation and Trends

2.7.1 Plant Sources Anti Cancer Agents Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Plant Sources Anti Cancer Agents Players Market Share by Revenue

2.7.3 Global Plant Sources Anti Cancer Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Plant Sources Anti Cancer Agents Retrospective Market Scenario by Region

3.1 Global Plant Sources Anti Cancer Agents Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Plant Sources Anti Cancer Agents Global Plant Sources Anti Cancer Agents Sales by Region: 2019-2030

3.2.1 Global Plant Sources Anti Cancer Agents Sales by Region: 2019-2024

3.2.2 Global Plant Sources Anti Cancer Agents Sales by Region: 2025-2030

3.3 Global Plant Sources Anti Cancer Agents Global Plant Sources Anti Cancer Agents Revenue by Region: 2019-2030

3.3.1 Global Plant Sources Anti Cancer Agents Revenue by Region: 2019-2024

3.3.2 Global Plant Sources Anti Cancer Agents Revenue by Region: 2025-2030

3.4 North America Plant Sources Anti Cancer Agents Market Facts & Figures by Country

3.4.1 North America Plant Sources Anti Cancer Agents Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Plant Sources Anti Cancer Agents Sales by Country (2019-2030)

3.4.3 North America Plant Sources Anti Cancer Agents Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Plant Sources Anti Cancer Agents Market Facts & Figures by Country

3.5.1 Europe Plant Sources Anti Cancer Agents Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Plant Sources Anti Cancer Agents Sales by Country (2019-2030)

3.5.3 Europe Plant Sources Anti Cancer Agents Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Plant Sources Anti Cancer Agents Market Facts & Figures by Country

3.6.1 Asia Pacific Plant Sources Anti Cancer Agents Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Plant Sources Anti Cancer Agents Sales by Country (2019-2030)

3.6.3 Asia Pacific Plant Sources Anti Cancer Agents Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Plant Sources Anti Cancer Agents Market Facts & Figures by Country

3.7.1 Latin America Plant Sources Anti Cancer Agents Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Plant Sources Anti Cancer Agents Sales by Country (2019-2030)

3.7.3 Latin America Plant Sources Anti Cancer Agents Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Plant Sources Anti Cancer Agents Market Facts & Figures by Country

3.8.1 Middle East and Africa Plant Sources Anti Cancer Agents Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Plant Sources Anti Cancer Agents Sales by Country (2019-2030)

3.8.3 Middle East and Africa Plant Sources Anti Cancer Agents Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Plant Sources Anti Cancer Agents Sales by Type (2019-2030)

4.1.1 Global Plant Sources Anti Cancer Agents Sales by Type (2019-2024)

4.1.2 Global Plant Sources Anti Cancer Agents Sales by Type (2025-2030)

4.1.3 Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2019-2030)

4.2 Global Plant Sources Anti Cancer Agents Revenue by Type (2019-2030)

4.2.1 Global Plant Sources Anti Cancer Agents Revenue by Type (2019-2024)

4.2.2 Global Plant Sources Anti Cancer Agents Revenue by Type (2025-2030)

4.2.3 Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2019-2030)

4.3 Global Plant Sources Anti Cancer Agents Price by Type (2019-2030)

5 Segment by Application

5.1 Global Plant Sources Anti Cancer Agents Sales by Application (2019-2030)

5.1.1 Global Plant Sources Anti Cancer Agents Sales by Application (2019-2024)

5.1.2 Global Plant Sources Anti Cancer Agents Sales by Application (2025-2030)

5.1.3 Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2019-2030)

5.2 Global Plant Sources Anti Cancer Agents Revenue by Application (2019-2030)

5.2.1 Global Plant Sources Anti Cancer Agents Revenue by Application (2019-2024)

5.2.2 Global Plant Sources Anti Cancer Agents Revenue by Application (2025-2030)

5.2.3 Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2019-2030)

5.3 Global Plant Sources Anti Cancer Agents Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Phyton

6.1.1 Phyton Corporation Information

6.1.2 Phyton Description and Business Overview

6.1.3 Phyton Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Phyton Plant Sources Anti Cancer Agents Product Portfolio

6.1.5 Phyton Recent Developments/Updates

6.2 ScinoPharm

6.2.1 ScinoPharm Corporation Information

6.2.2 ScinoPharm Description and Business Overview

6.2.3 ScinoPharm Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.2.4 ScinoPharm Plant Sources Anti Cancer Agents Product Portfolio

6.2.5 ScinoPharm Recent Developments/Updates

6.3 Novasep

6.3.1 Novasep Corporation Information

6.3.2 Novasep Description and Business Overview

6.3.3 Novasep Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Novasep Plant Sources Anti Cancer Agents Product Portfolio

6.3.5 Novasep Recent Developments/Updates

6.4 Samyang

6.4.1 Samyang Corporation Information

6.4.2 Samyang Description and Business Overview

6.4.3 Samyang Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Samyang Plant Sources Anti Cancer Agents Product Portfolio

6.4.5 Samyang Recent Developments/Updates

6.5 Polymed

6.5.1 Polymed Corporation Information

6.5.2 Polymed Description and Business Overview

6.5.3 Polymed Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Polymed Plant Sources Anti Cancer Agents Product Portfolio

6.5.5 Polymed Recent Developments/Updates

6.6 TAPI (Teva)

6.6.1 TAPI (Teva) Corporation Information

6.6.2 TAPI (Teva) Description and Business Overview

6.6.3 TAPI (Teva) Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.6.4 TAPI (Teva) Plant Sources Anti Cancer Agents Product Portfolio

6.6.5 TAPI (Teva) Recent Developments/Updates

6.7 Fresenius-kabi

6.6.1 Fresenius-kabi Corporation Information

6.6.2 Fresenius-kabi Description and Business Overview

6.6.3 Fresenius-kabi Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Fresenius-kabi Plant Sources Anti Cancer Agents Product Portfolio

6.7.5 Fresenius-kabi Recent Developments/Updates

6.8 Huiang biopharma

6.8.1 Huiang biopharma Corporation Information

6.8.2 Huiang biopharma Description and Business Overview

6.8.3 Huiang biopharma Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Huiang biopharma Plant Sources Anti Cancer Agents Product Portfolio

6.8.5 Huiang biopharma Recent Developments/Updates

6.9 Southpharma

6.9.1 Southpharma Corporation Information

6.9.2 Southpharma Description and Business Overview

6.9.3 Southpharma Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Southpharma Plant Sources Anti Cancer Agents Product Portfolio

6.9.5 Southpharma Recent Developments/Updates

6.10 Yunnan Hande

6.10.1 Yunnan Hande Corporation Information

6.10.2 Yunnan Hande Description and Business Overview

6.10.3 Yunnan Hande Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Yunnan Hande Plant Sources Anti Cancer Agents Product Portfolio

6.10.5 Yunnan Hande Recent Developments/Updates

6.11 Hainan Yew Pharm

6.11.1 Hainan Yew Pharm Corporation Information

6.11.2 Hainan Yew Pharm Plant Sources Anti Cancer Agents Description and Business Overview

6.11.3 Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Hainan Yew Pharm Plant Sources Anti Cancer Agents Product Portfolio

6.11.5 Hainan Yew Pharm Recent Developments/Updates

6.12 Jiangsu Yew Biotechnology

6.12.1 Jiangsu Yew Biotechnology Corporation Information

6.12.2 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Description and Business Overview

6.12.3 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Product Portfolio

6.12.5 Jiangsu Yew Biotechnology Recent Developments/Updates

6.13 West-Ward Pharmaceuticals

6.13.1 West-Ward Pharmaceuticals Corporation Information

6.13.2 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Description and Business Overview

6.13.3 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.13.4 West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Product Portfolio

6.13.5 West-Ward Pharmaceuticals Recent Developments/Updates

6.14 Pfizer

6.14.1 Pfizer Corporation Information

6.14.2 Pfizer Plant Sources Anti Cancer Agents Description and Business Overview

6.14.3 Pfizer Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Pfizer Plant Sources Anti Cancer Agents Product Portfolio

6.14.5 Pfizer Recent Developments/Updates

6.15 Actiza Pharmaceutical

6.15.1 Actiza Pharmaceutical Corporation Information

6.15.2 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Description and Business Overview

6.15.3 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Actiza Pharmaceutical Plant Sources Anti Cancer Agents Product Portfolio

6.15.5 Actiza Pharmaceutical Recent Developments/Updates

6.16 Getwell

6.16.1 Getwell Corporation Information

6.16.2 Getwell Plant Sources Anti Cancer Agents Description and Business Overview

6.16.3 Getwell Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.16.4 Getwell Plant Sources Anti Cancer Agents Product Portfolio

6.16.5 Getwell Recent Developments/Updates

6.17 Taj Pharma

6.17.1 Taj Pharma Corporation Information

6.17.2 Taj Pharma Plant Sources Anti Cancer Agents Description and Business Overview

6.17.3 Taj Pharma Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.17.4 Taj Pharma Plant Sources Anti Cancer Agents Product Portfolio

6.17.5 Taj Pharma Recent Developments/Updates

6.18 Cipla

6.18.1 Cipla Corporation Information

6.18.2 Cipla Plant Sources Anti Cancer Agents Description and Business Overview

6.18.3 Cipla Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.18.4 Cipla Plant Sources Anti Cancer Agents Product Portfolio

6.18.5 Cipla Recent Developments/Updates

6.19 Salius

6.19.1 Salius Corporation Information

6.19.2 Salius Plant Sources Anti Cancer Agents Description and Business Overview

6.19.3 Salius Plant Sources Anti Cancer Agents Sales, Revenue and Gross Margin (2019-2024)

6.19.4 Salius Plant Sources Anti Cancer Agents Product Portfolio

6.19.5 Salius Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Plant Sources Anti Cancer Agents Industry Chain Analysis

7.2 Plant Sources Anti Cancer Agents Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Plant Sources Anti Cancer Agents Production Mode & Process

7.4 Plant Sources Anti Cancer Agents Sales and Marketing

7.4.1 Plant Sources Anti Cancer Agents Sales Channels

7.4.2 Plant Sources Anti Cancer Agents Distributors

7.5 Plant Sources Anti Cancer Agents Customers

8 Plant Sources Anti Cancer Agents Market Dynamics

8.1 Plant Sources Anti Cancer Agents Industry Trends

8.2 Plant Sources Anti Cancer Agents Market Drivers

8.3 Plant Sources Anti Cancer Agents Market Challenges

8.4 Plant Sources Anti Cancer Agents Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Jiangsu Yew Biotechnology

West Ward Pharmaceuticals

Pfizer Inc

Actiza Pharmaceutical

List of Tables

Table 1. Global Plant Sources Anti Cancer Agents Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Plant Sources Anti Cancer Agents Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Plant Sources Anti Cancer Agents Market Competitive Situation by Manufacturers in 2023

Table 4. Global Plant Sources Anti Cancer Agents Sales (MT) of Key Manufacturers (2019-2024)

Table 5. Global Plant Sources Anti Cancer Agents Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Plant Sources Anti Cancer Agents Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Plant Sources Anti Cancer Agents Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Plant Sources Anti Cancer Agents Average Price (USD/Kg) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Plant Sources Anti Cancer Agents, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Plant Sources Anti Cancer Agents, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Plant Sources Anti Cancer Agents, Product Type & Application

Table 12. Global Key Manufacturers of Plant Sources Anti Cancer Agents, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Plant Sources Anti Cancer Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plant Sources Anti Cancer Agents as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Plant Sources Anti Cancer Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Plant Sources Anti Cancer Agents Sales by Region (2019-2024) & (MT)

Table 18. Global Plant Sources Anti Cancer Agents Sales Market Share by Region (2019-2024)

Table 19. Global Plant Sources Anti Cancer Agents Sales by Region (2025-2030) & (MT)

Table 20. Global Plant Sources Anti Cancer Agents Sales Market Share by Region (2025-2030)

Table 21. Global Plant Sources Anti Cancer Agents Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Plant Sources Anti Cancer Agents Revenue Market Share by Region (2019-2024)

Table 23. Global Plant Sources Anti Cancer Agents Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Plant Sources Anti Cancer Agents Revenue Market Share by Region (2025-2030)

Table 25. North America Plant Sources Anti Cancer Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Plant Sources Anti Cancer Agents Sales by Country (2019-2024) & (MT)

Table 27. North America Plant Sources Anti Cancer Agents Sales by Country (2025-2030) & (MT)

Table 28. North America Plant Sources Anti Cancer Agents Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Plant Sources Anti Cancer Agents Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Plant Sources Anti Cancer Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Plant Sources Anti Cancer Agents Sales by Country (2019-2024) & (MT)

Table 32. Europe Plant Sources Anti Cancer Agents Sales by Country (2025-2030) & (MT)

Table 33. Europe Plant Sources Anti Cancer Agents Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Plant Sources Anti Cancer Agents Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Plant Sources Anti Cancer Agents Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Plant Sources Anti Cancer Agents Sales by Region (2019-2024) & (MT)

Table 37. Asia Pacific Plant Sources Anti Cancer Agents Sales by Region (2025-2030) & (MT)

Table 38. Asia Pacific Plant Sources Anti Cancer Agents Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Plant Sources Anti Cancer Agents Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Plant Sources Anti Cancer Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Plant Sources Anti Cancer Agents Sales by Country (2019-2024) & (MT)

Table 42. Latin America Plant Sources Anti Cancer Agents Sales by Country (2025-2030) & (MT)

Table 43. Latin America Plant Sources Anti Cancer Agents Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Plant Sources Anti Cancer Agents Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Plant Sources Anti Cancer Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Plant Sources Anti Cancer Agents Sales by Country (2019-2024) & (MT)

Table 47. Middle East & Africa Plant Sources Anti Cancer Agents Sales by Country (2025-2030) & (MT)

Table 48. Middle East & Africa Plant Sources Anti Cancer Agents Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Plant Sources Anti Cancer Agents Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Plant Sources Anti Cancer Agents Sales (MT) by Type (2019-2024)

Table 51. Global Plant Sources Anti Cancer Agents Sales (MT) by Type (2025-2030)

Table 52. Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2019-2024)

Table 53. Global Plant Sources Anti Cancer Agents Sales Market Share by Type (2025-2030)

Table 54. Global Plant Sources Anti Cancer Agents Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Plant Sources Anti Cancer Agents Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2019-2024)

Table 57. Global Plant Sources Anti Cancer Agents Revenue Market Share by Type (2025-2030)

Table 58. Global Plant Sources Anti Cancer Agents Price (USD/Kg) by Type (2019-2024)

Table 59. Global Plant Sources Anti Cancer Agents Price (USD/Kg) by Type (2025-2030)

Table 60. Global Plant Sources Anti Cancer Agents Sales (MT) by Application (2019-2024)

Table 61. Global Plant Sources Anti Cancer Agents Sales (MT) by Application (2025-2030)

Table 62. Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2019-2024)

Table 63. Global Plant Sources Anti Cancer Agents Sales Market Share by Application (2025-2030)

Table 64. Global Plant Sources Anti Cancer Agents Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Plant Sources Anti Cancer Agents Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2019-2024)

Table 67. Global Plant Sources Anti Cancer Agents Revenue Market Share by Application (2025-2030)

Table 68. Global Plant Sources Anti Cancer Agents Price (USD/Kg) by Application (2019-2024)

Table 69. Global Plant Sources Anti Cancer Agents Price (USD/Kg) by Application (2025-2030)

Table 70. Phyton Corporation Information

Table 71. Phyton Description and Business Overview

Table 72. Phyton Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 73. Phyton Plant Sources Anti Cancer Agents Product

Table 74. Phyton Recent Developments/Updates

Table 75. ScinoPharm Corporation Information

Table 76. ScinoPharm Description and Business Overview

Table 77. ScinoPharm Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 78. ScinoPharm Plant Sources Anti Cancer Agents Product

Table 79. ScinoPharm Recent Developments/Updates

Table 80. Novasep Corporation Information

Table 81. Novasep Description and Business Overview

Table 82. Novasep Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 83. Novasep Plant Sources Anti Cancer Agents Product

Table 84. Novasep Recent Developments/Updates

Table 85. Samyang Corporation Information

Table 86. Samyang Description and Business Overview

Table 87. Samyang Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 88. Samyang Plant Sources Anti Cancer Agents Product

Table 89. Samyang Recent Developments/Updates

Table 90. Polymed Corporation Information

Table 91. Polymed Description and Business Overview

Table 92. Polymed Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 93. Polymed Plant Sources Anti Cancer Agents Product

Table 94. Polymed Recent Developments/Updates

Table 95. TAPI (Teva) Corporation Information

Table 96. TAPI (Teva) Description and Business Overview

Table 97. TAPI (Teva) Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 98. TAPI (Teva) Plant Sources Anti Cancer Agents Product

Table 99. TAPI (Teva) Recent Developments/Updates

Table 100. Fresenius-kabi Corporation Information

Table 101. Fresenius-kabi Description and Business Overview

Table 102. Fresenius-kabi Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 103. Fresenius-kabi Plant Sources Anti Cancer Agents Product

Table 104. Fresenius-kabi Recent Developments/Updates

Table 105. Huiang biopharma Corporation Information

Table 106. Huiang biopharma Description and Business Overview

Table 107. Huiang biopharma Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 108. Huiang biopharma Plant Sources Anti Cancer Agents Product

Table 109. Huiang biopharma Recent Developments/Updates

Table 110. Southpharma Corporation Information

Table 111. Southpharma Description and Business Overview

Table 112. Southpharma Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 113. Southpharma Plant Sources Anti Cancer Agents Product

Table 114. Southpharma Recent Developments/Updates

Table 115. Yunnan Hande Corporation Information

Table 116. Yunnan Hande Description and Business Overview

Table 117. Yunnan Hande Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 118. Yunnan Hande Plant Sources Anti Cancer Agents Product

Table 119. Yunnan Hande Recent Developments/Updates

Table 120. Hainan Yew Pharm Corporation Information

Table 121. Hainan Yew Pharm Description and Business Overview

Table 122. Hainan Yew Pharm Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 123. Hainan Yew Pharm Plant Sources Anti Cancer Agents Product

Table 124. Hainan Yew Pharm Recent Developments/Updates

Table 125. Jiangsu Yew Biotechnology Corporation Information

Table 126. Jiangsu Yew Biotechnology Description and Business Overview

Table 127. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 128. Jiangsu Yew Biotechnology Plant Sources Anti Cancer Agents Product

Table 129. Jiangsu Yew Biotechnology Recent Developments/Updates

Table 130. West-Ward Pharmaceuticals Corporation Information

Table 131. West-Ward Pharmaceuticals Description and Business Overview

Table 132. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 133. West-Ward Pharmaceuticals Plant Sources Anti Cancer Agents Product

Table 134. West-Ward Pharmaceuticals Recent Developments/Updates

Table 135. Pfizer Corporation Information

Table 136. Pfizer Description and Business Overview

Table 137. Pfizer Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 138. Pfizer Plant Sources Anti Cancer Agents Product

Table 139. Pfizer Recent Developments/Updates

Table 140. Actiza Pharmaceutical Corporation Information

Table 141. Actiza Pharmaceutical Description and Business Overview

Table 142. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 143. Actiza Pharmaceutical Plant Sources Anti Cancer Agents Product

Table 144. Actiza Pharmaceutical Recent Developments/Updates

Table 145. Getwell Corporation Information

Table 146. Getwell Description and Business Overview

Table 147. Getwell Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 148. Getwell Plant Sources Anti Cancer Agents Product

Table 149. Getwell Recent Developments/Updates

Table 150. Taj Pharma Corporation Information

Table 151. Taj Pharma Description and Business Overview

Table 152. Taj Pharma Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 153. Taj Pharma Plant Sources Anti Cancer Agents Product

Table 154. Taj Pharma Recent Developments/Updates

Table 155. Cipla Corporation Information

Table 156. Cipla Description and Business Overview

Table 157. Cipla Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 158. Cipla Plant Sources Anti Cancer Agents Product

Table 159. Cipla Recent Developments/Updates

Table 160. Salius Corporation Information

Table 161. Salius Description and Business Overview

Table 162. Salius Plant Sources Anti Cancer Agents Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 163. Salius Plant Sources Anti Cancer Agents Product

Table 164. Salius Recent Developments/Updates

Table 165. Key Raw Materials Lists

Table 166. Raw Materials Key Suppliers Lists

Table 167. Plant Sources Anti Cancer Agents Distributors List

Table 168. Plant Sources Anti Cancer Agents Customers List

Table 169. Plant Sources Anti Cancer Agents Market Trends

Table 170. Plant Sources Anti Cancer Agents Market Drivers

Table 171. Plant Sources Anti Cancer Agents Market Challenges

Table 172. Plant Sources Anti Cancer Agents Market Restraints

Table 173. Research Programs/Design for This Report

Table 174. Key Data Information from Secondary Sources

Table 175. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Plant Sources Anti Cancer Agents

Figure 2. Global Plant Sources Anti Cancer Agents Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Plant Sources Anti Cancer Agents Market Share by Type in 2023 & 2030

Figure 4. Paclitaxel Product Picture

Figure 5. Vinorelbine Product Picture

Figure 6. Irinotecan Product Picture

Figure 7. Hydroxycamptothecin Product Picture

Figure 8. Docetaxel Product Picture

Figure 9. Other Product Picture

Figure 10. Global Plant Sources Anti Cancer Agents Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Plant Sources Anti Cancer Agents Market Share by Application in 2023 & 2030

Figure 12. Ovarian Cancer

Figure 13. Cervical Cancer

Figure 14. Breast Cancer

Figure 15. Other

Figure 16. Global Plant Sources Anti Cancer Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Plant Sources Anti Cancer Agents Market Size (2019-2030) & (US$ Million)

Figure 18. Global Plant Sources Anti Cancer Agents Sales (2019-2030) & (MT)

Figure 19. Global Plant Sources Anti Cancer Agents Average Price (USD/Kg) & (2019-2030)

Figure 20. Plant Sources Anti Cancer Agents Report Years Considered

Figure 21. Plant Sources Anti Cancer Agents Sales Share by Manufacturers in 2023

Figure 22. Global Plant Sources Anti Cancer Agents Revenue Share by Manufacturers in 2023

Figure 23. The Global 5 and 10 Largest Plant Sources Anti Cancer Agents Players: Market Share by Revenue in 2023

Figure 24. Plant Sources Anti Cancer Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 25. Global Plant Sources Anti Cancer Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 26. North America Plant Sources Anti Cancer Agents Sales Market Share by Country (2019-2030)

Figure 27. North America Plant Sources Anti Cancer Agents Revenue Market Share by Country (2019-2030)

Figure 28. U.S. Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Canada Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Europe Plant Sources Anti Cancer Agents Sales Market Share by Country (2019-2030)

Figure 31. Europe Plant Sources Anti Cancer Agents Revenue Market Share by Country (2019-2030)

Figure 32. Germany Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. France Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. U.K. Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Italy Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Russia Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Asia Pacific Plant Sources Anti Cancer Agents Sales Market Share by Region (2019-2030)

Figure 38. Asia Pacific Plant Sources Anti Cancer Agents Revenue Market Share by Region (2019-2030)

Figure 39. China Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Japan Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. South Korea Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. India Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Australia Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Taiwan Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Indonesia Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Thailand Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Malaysia Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Philippines Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Latin America Plant Sources Anti Cancer Agents Sales Market Share by Country (2019-2030)

Figure 50. Latin America Plant Sources Anti Cancer Agents Revenue Market Share by Country (2019-2030)

Figure 51. Mexico Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Brazil Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Argentina Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Middle East & Africa Plant Sources Anti Cancer Agents Sales Market Share by Country (2019-2030)

Figure 55. Middle East & Africa Plant Sources Anti Cancer Agents Revenue Market Share by Country (2019-2030)

Figure 56. Turkey Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. U.A.E Plant Sources Anti Cancer Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. Global Sales Market Share of Plant Sources Anti Cancer Agents by Type (2019-2030)

Figure 60. Global Revenue Market Share of Plant Sources Anti Cancer Agents by Type (2019-2030)

Figure 61. Global Plant Sources Anti Cancer Agents Price (USD/Kg) by Type (2019-2030)

Figure 62. Global Sales Market Share of Plant Sources Anti Cancer Agents by Application (2019-2030)

Figure 63. Global Revenue Market Share of Plant Sources Anti Cancer Agents by Application (2019-2030)

Figure 64. Global Plant Sources Anti Cancer Agents Price (USD/Kg) by Application (2019-2030)

Figure 65. Plant Sources Anti Cancer Agents Value Chain

Figure 66. Plant Sources Anti Cancer Agents Production Process

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Distributors Profiles

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Color Detection Sensors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G9623

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Appendix Cancer Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2H1312

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions